Position in LLY
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$266,943,963
+$58,300,577 QoQ
Shares Held
222,559
-1.9% QoQ
Ownership
0.024%
of shares outstanding
% of Portfolio
1.65%
of 13F equity value
Holder Rank
#230
of 4,601 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026XPONANCE LLC holds $673,665,379 across 15 Drug Manufacturers - General names. LLY ranks #1 (39.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
222,559 | $266,943,963 | |
| 2 | JNJ |
Johnson & Johnson
|
466,851 | $118,566,148 | |
| 3 | ABBV |
AbbVie Inc.
|
350,912 | $88,303,495 | |
| 4 | MRK |
Merck & Co., Inc.
|
473,483 | $60,842,565 | |
| 5 | AMGN |
Amgen Inc
|
133,818 | $48,458,174 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
238,168 | $30,090,145 | |
| 7 | PFE |
Pfizer Inc
|
1,108,420 | $26,690,753 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
444,025 | $25,584,720 |
All Filings in LLY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $266,943,963 | 222,559 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $208,643,386 | 226,843 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $223,879,507 | 208,322 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $150,356,017 | 197,059 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $154,292,372 | 197,930 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $157,916,469 | 191,203 | Shares | Sole | 2025-05-01 | |
| 2024-12-31 | $144,001,160 | 186,530 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $165,395,252 | 186,689 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $176,389,753 | 194,824 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $151,769,104 | 195,086 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $111,342,966 | 191,009 | Shares | Sole | 2024-01-31 | |
| 2023-09-30 | $101,673,874 | 189,291 | Shares | Sole | 2023-10-24 | |
| 2023-06-30 | $88,496,994 | 188,701 | Shares | Sole | 2023-07-14 | |
| 2023-03-31 | $57,338,433 | 166,963 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $59,548,142 | 162,771 | Shares | Sole | 2023-01-24 | |
| 2022-09-30 | $47,309,985 | 146,312 | Shares | Sole | 2022-10-24 | |
| 2022-06-30 | $44,055,075 | 135,876 | Shares | Sole | 2022-08-02 | |
| 2022-03-31 | $38,696,605 | 135,128 | Shares | Sole | 2022-04-20 | |
| 2021-12-31 | $33,046,684 | 119,639 | Shares | Sole | 2022-01-31 | |
| 2021-09-30 | $28,350,297 | 122,702 | Shares | Sole | 2021-11-05 | |
| 2021-06-30 | $30,734,564 | 133,908 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $27,914,644 | 149,420 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $25,304,895 | 149,875 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $22,058,532 | 149,024 | Shares | Sole | 2020-10-26 | |
| 2020-06-30 | $25,773,140 | 156,981 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||